X0306 4 2014-02-24 0001311230 SOLAZYME INC SZYM 0001333277 Quinlan Paul T SOLAZYME, INC. 225 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080 0 1 0 0 General Counsel Common Stock 2014-02-24 4 M 0 6000 2.35 A 98239 D Common Stock 2014-02-24 4 S 0 8239 11.6133 D 90000 D Employee Stock Option (right to buy) 2.35 2014-02-24 4 M 0 6000 0 D 2020-06-13 Common Stock 6000 58000 D Includes 2,239 shares acquired under the Solazyme Employee Stock Purchase Plan on February 14, 2014. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.28 to $11.93, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. All shares immediately exercisable. The original option grant vested as to 1/4 of the shares on May 24, 2011 and 1/36 per month of the remainder thereafter. /s/ Paul Quinlan 2014-02-24